SCHEMBL1720864

SCHEMBL1720864

CCCn1c(-c2cccc(C(F)(F)F)c2)nc(=O)c2c1N=C(c1ccc(OCc3ccccc3)cc1)[N]2

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 3/20 0.43
GPR34 Q9UPC5 1/20 0.41
ADORA1 P30542 2/20 0.40
PPARD Q03181 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
XBP1 P17861 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NR4A2 P43354 1/20 0.39
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
FFAR1 O14842 1/20 0.38
MAOB P27338 2/20 0.38
MAOA P21397 1/20 0.38
PTGDR2 Q9Y5Y4 1/20 0.38
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1721091 0.88 ADORA1 (0.43) ADORA2BADORA1PPARDALDH1A1HPGD
SCHEMBL1721175 0.88 ADORA2B (0.44) ADORA2BGPR34ADORA1PPARDALDH1A1
SCHEMBL1721383 0.83 ADORA2B (0.37) ADORA2BADORA1MAPT
SCHEMBL30891856 0.76 ADORA1 (0.58) ADORA2BADORA1
SCHEMBL2685011 0.76 ADORA1 (0.58) ADORA2BADORA1
SCHEMBL2686035 0.75 ADORA1 (0.43) ADORA2BGPR34ADORA1PPARDALDH1A1
SCHEMBL1720580 0.70 SCD (0.38) ADORA2BADORA1
SCHEMBL11435944 0.69 GSTP1 (0.50) GPR34PPARDNR4A2FFAR1MAOB
SCHEMBL1865267 0.68 ADORA1 (0.44) ADORA2BADORA1ALDH1A1MAOBMAOA
SCHEMBL1946830 0.64 ADORA2B (0.62) ADORA2BADORA1ALDH1A1HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3727391-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER Impetis Biosciences Ltd. (IN) 2020-10-28 EP claimed
EP-3727391-A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER Impetis Biosciences Ltd. (IN) 2020-10-28 EP disclosed
EP-2405917-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS Advinus Therapeutics Private Limited (IN) 2012-01-18 EP disclosed
WO-2010103547-A2 SUBSTITUTED FUSED PYRIMIDINE COMPOUNDS ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-09-16 WO disclosed